---
id: bacterial-keratitis_049
category: clinical_syndromes
tags: [keratitis, corneal-ulcer, pseudomonas, contact-lens, fortified-antibiotics, eye-infections]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Bacterial Keratitis (Corneal Ulcer)

**Q:** What are the risk factors, pathogens, and treatment for bacterial keratitis?

**A:**

**Definition:**
Infection of the cornea (keratitis) with epithelial defect and stromal infiltrate → corneal ulcer

**Risk Factors:**

| **Risk Factor** | **Associated Pathogen** |
|-----------------|-------------------------|
| **Contact lens use** (most common) | **Pseudomonas aeruginosa** (#1), Staph aureus |
| **Trauma** (corneal abrasion, foreign body) | Staph aureus, Strep pneumoniae |
| **Corneal disease** (dry eye, exposure keratopathy) | Staph aureus, Strep species |
| **Post-surgical** (LASIK, cataract) | Staph epidermidis, Staph aureus |
| **Immunosuppression** | Pseudomonas, fungi |

**Clinical Presentation:**
- **Pain** (moderate to severe)
- **Photophobia**
- **Decreased vision**
- **Corneal infiltrate/ulcer** (white opacity)
- **Hypopyon** (layered WBCs in anterior chamber) - severe cases

**Key Pathogens:**
- **Pseudomonas aeruginosa:** Most severe, rapid progression, contact lens-associated
- **Staphylococcus aureus:** Common, less aggressive
- **Streptococcus pneumoniae:** Aggressive, can perforate
- **Moraxella:** Indolent, chronic ulcer

**Diagnosis:**
- **Corneal scraping** for culture (before starting antibiotics if possible)
- Gram stain, culture (blood agar, chocolate agar)
- PCR if available

**Treatment:**

**Empiric Treatment (Start IMMEDIATELY):**

| **Severity** | **Regimen** |
|--------------|-------------|
| **Mild-moderate** (peripheral, <2mm) | **Fluoroquinolone monotherapy**<br>• Moxifloxacin 0.5% or gatifloxacin 0.3%<br>• Every 30-60 min x 24-48h, then taper |
| **Severe** (central, >2mm, vision-threatening) | **Fortified antibiotics**<br>• Vancomycin 25-50 mg/mL (Gram+) q1h<br>ALTERNATING with<br>• Tobramycin 14 mg/mL (Gram-) q1h<br>**OR**<br>• Cefazolin 50 mg/mL + tobramycin 14 mg/mL |

**Fortified Antibiotics (Must be compounded by pharmacy):**
- Used around-the-clock initially (q1h)
- Alternating drops (e.g., vanc q1h on the hour, tobra q1h on the half-hour)
- **80% of US clinicians use fortified antibiotics for severe cases**

**Contact Lens-Associated Keratitis:**
- **ALWAYS cover Pseudomonas**
- Fluoroquinolone preferred (anti-Pseudomonal)
- **Remove contact lens immediately, discard case**
- Never resume lens wear until completely healed + ophthalmology clearance

**Complications:**
- Corneal perforation
- Endophthalmitis
- Corneal scarring → permanent vision loss

**Ophthalmology Referral:**
- **URGENT** for all bacterial keratitis
- This is an ophthalmologic emergency

**Mnemonic: "Keratitis = Contact lens + Pain → Pseudomonas, Treat Pronto"**
- **K**eratitis
- **C**ontact lens
- **P**ain + photophobia
- **P**seudomonas (#1 cause)
- **P**ronto (urgent treatment)

**Clinical Pearls:**
- **Pseudomonas keratitis = ophthalmologic emergency** (can perforate in 24-48h)
- Contact lens wearers with red eye + pain → keratitis until proven otherwise
- Fluoroquinolone monotherapy OK for mild-moderate; fortified for severe
- Never delay treatment for culture results

**Media:** None

**Sources:** [EyeWiki 2024 - Bacterial keratitis], [PMC 2012 - Pseudomonas keratitis management], [Frontiers 2021 - Contact lens bacterial keratitis systematic review], [Medscape 2024], [PubMed 2017 - Empirical treatment international survey]
